longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

RMBL

RMBL
3.2100.00%( 0.000 )

LongbridgeAI

Stocks to watch: Far East Orchard, UltraGreen.ai, iX Biopharma

Businesstimes News
Oct 5, 2026 at 12:54 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Far East Orchard acquires a 42% stake in FEHT managers for S$28.3 million, boosting assets under management to S$3.9 billion. UltraGreen.ai announced board changes, with Nicky Tan replacing Hsieh Fu Hua as lead independent director. iX Biopharma settled A$1.7 million debt by issuing approximately 2.7 million new shares at S$0.5627 each to private investor Vincent Lee.

[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Monday (Oct 5):

Far East Orchard , Far East Hospitality Trust (FEHT) : Far East Orchard is acquiring an additional 42 per cent stake in the managers of FEHT for S$28.3 million. This transaction will propel its core assets under management past its S$3 billion target to S$3.9 billion, Far East Orchard announced on Monday. Shares of Far East Orchard ended 1 per cent or S$0.01 higher at S$1.06 on Friday. Shares of FEHT ended at S$0.51, 1.9 per cent or S$0.01 lower.

UltraGreen.ai : The group announced a number of board changes on Friday, as part of its next phase of development. Lead independent director Hsieh Fu Hua stepped down the same day. Nicky Tan, currently an independent director, was appointed lead independent director in his place. Shares of UltraGreen.ai closed down 0.9 per cent or US$0.005 at US$0.565 on Friday, before the news.

iX Biopharma : The Catalist-listed company announced on Monday that it entered into an agreement to settle an outstanding debt of A$1.7 million (US$1.2 million) through the issuance of new ordinary shares. The debt capitalisation agreement was signed on Saturday with Australia-based private businessman Vincent Lee. iX Biopharma will allot and issue close to 2.7 million new shares for S$0.5627 each. Shares of iX Biopharma ended at S$0.56, up 1.8 per cent or S$0.01, on Friday.

Login to unlock932characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Oct 4, 2026 at 06:03 AMThe Week Ahead: Fed September Minutes, PepsiCo and Delta Earnings in Focus
  • Sep 25, 2026 at 12:36 AMStocks to watch: Far East Orchard, CSE Global, Addvalue Tech
  • Sep 17, 2026 at 12:54 AMStock to watch: Ultragreen.ai
  • Aug 25, 2026 at 12:30 AMStocks to watch: Frasers Property, UltraGreen.ai
  • Jul 20, 2026 at 12:26 AMStocks to watch: SIA, Far East Orchard

Related Stocks

IX Biopharma

IX Biopharma

SG42C

+0.89%

Far East Orchard

Far East Orchard

SGO10

-0.94%

ULTRAGREEN AI USD

ULTRAGREEN AI USD

SGULG

-0.88%